Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1993-08-02
1994-11-01
Wax, Robert A.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
435 15, 435 691, 435 9151, 935 14, 935 17, 25218311, 536 232, 536 2372, C12Q 148, C12Q 168, C08L 500, C12N 912
Patent
active
053607147
ABSTRACT:
An enzymatically active composition of matter, comprising an extracellular combination of a substantially virus-free hepadnavirus polymerase gene product and an RNA template for hepadnavirus minus strand DNA synthesis, is provided. The composition possesses a DNA priming activity and a reverse transcriptase activity. The hepadnavirus polymerase gene product is produced by in vitro expression of a hepadnavirus pol gene.
The enzymatically active composition of matter is used in rapid in vitro assays to screen potential anti-hepadnaviral agents. Assays for various functions of the hepadnavirus DNA polymerase are provided, including: (1) binding of the polymerase gene product to hepadnavirus pre-genomic RNA; (2) DNA priming activity of the polymerase gene product; and (3) reverse transcriptase activity of the polymerase gene product.
REFERENCES:
patent: 4937074 (1990-06-01), Venkateswaran et al.
patent: 4968674 (1990-11-01), Taniyama et al.
patent: 4997926 (1991-03-01), Haertle et al.
T. Wu et al., J. Virol., 65: 2155-63 (1991).
H. Meisel et al., J. Med. Virol., 30: 137-141 (1990).
L. Chang et al., J. Virol., 64: 5553-58 (1990).
G. Civitico et al., J. Med. Virol., 31: 90-97 (1990).
W. Offensperger et al., Virology, 164: 48-54 (1988).
H. Lin et al., J. Med. Virol., 12: 61-70 (1983).
C. Howard, J. Med. Virol., 3: 81-86 (1978).
P. L. Marion, Current Topics in Microbiology and Immunology, 168: 168-183 (1991).
M. Bavand et al., J. Virol., 63: 1019-1021 (1989).
E. Mandart et al., J. Virol., 49: 782-792 (1984).
J. C. Pugh et al., J. Virol., 62: 3513-3516 (1988).
L. Chang et al., Nature, 337: 364-368 (1989).
H. Schlicht, Cell, 56: 85-92 (1989).
M. Bavand et al., J. Virol., 62: 626-628 (1988).
R. Bartenschlager et al., Nucleic Acids Research, 20: 195-202 (1992).
C. G. Lin et al., Virology, 188: 342-352 (1992).
E. McGlynn et al., J. Gen. Virol., 73: 1515-1519 (1992).
H. G. Kochel et al., Virology, 182: 94-101 (1991).
G. Foster et al., Proc. Natl. Acad. Sci. USA, 88: 28882892 (1991).
D. Ganem et al., Ann. rev. Biochem., 56:651-93 (1987).
M. Junker-Niepmann et al., The EMBO Journal, 9: 3389-3396 (1990).
K. L. Molnar-Kimber et al., J. Virol., 51: 181-191 (1984).
C. Seeger et al., Science, 232: 477-484 (1986).
C. Seeger et al., J. Virol., 64: 16-23 (1990).
C. Seeger et al., J. Virol., 65: 5190-5195 (1991).
J. Summers et al., Cell, 29: 403-415 (1982).
J. Tavis et al., Biochemistry, 90: 4107-4111 (1993).
J. Tuttleman et al., Cell, 47: 451-460 (1986).
R. Hirsch et al., Nature, 344: 552-555 (1990).
G.-H. Wang & C. Seeger, Cell, 71: 663-70 (1993).
Fox Chase Cancer Center
Prouty Rebecca
Wax Robert A.
LandOfFree
Hepadnavirus polymerase gene product having RNA-dependent DNA pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepadnavirus polymerase gene product having RNA-dependent DNA pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepadnavirus polymerase gene product having RNA-dependent DNA pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1802013